Affinity Asset Advisors, LLC

SEC CIK: 0001773195
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

MNPR holding history

Monopar Therapeutics in every 13F filed by Affinity Asset Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MNPR overview All 13F holders of MNPR Full Q2 2026 holdings

Shares (Q4 2025): 0; Sold out in Q4 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q1 2025

Holdings of MNPR by Affinity Asset Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2025	0	$0	0.0%	−79,483−100.0%	Sold out	Holders
Q3 2025	79,483	$6.49M	0.6%	+11,983+17.8%	Added	Holders
Q2 2025	67,500	$2.42M	0.4%	+5,500+8.9%	Added	Holders
Q1 2025	62,000	$2.26M	0.4%	+62,000	New	Holders